Terms: = Colorectal cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
50 results:
1. Synthesis and characterisation of a nucleotide based pro-drug formulated with a peptide into a nano-chemotherapy for colorectal cancer.
Wilson JJ; Bennie L; Eguaogie O; Elkashif A; Conlon PF; Jena L; McErlean E; Buckley N; Englert K; Dunne NJ; Tucker JHR; Vyle JS; McCarthy HO
J Control Release; 2024 May; 369():63-74. PubMed ID: 38513729
[TBL] [Abstract] [Full Text] [Related]
2. Preventative strategies for low anterior resection syndrome.
Brock H; Lambrineas L; Ong HI; Chen WY; Das A; Edsell A; Proud D; Carrington E; Smart P; Mohan H; Burgess A
Tech Coloproctol; 2023 Dec; 28(1):10. PubMed ID: 38091118
[TBL] [Abstract] [Full Text] [Related]
3. Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.
Meng Q; Zhao J; Yu Y; Wang K; Ren J; Xu C; Wang Y; Wang G
BMC Cancer; 2023 Feb; 23(1):191. PubMed ID: 36849918
[TBL] [Abstract] [Full Text] [Related]
4. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
[TBL] [Abstract] [Full Text] [Related]
5. Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon cancer.
Lin H; Cao B
Dis Markers; 2022; 2022():3592990. PubMed ID: 35937946
[TBL] [Abstract] [Full Text] [Related]
6. MYC-Induced Upregulation of Lncrna ELFN1-AS1 Contributes to Tumor Growth in colorectal cancer via Epigenetically Silencing TPM1.
Li C; Hong S; Hu H; Liu T; Yan G; Sun D
Mol Cancer Res; 2022 Nov; 20(11):1697-1708. PubMed ID: 35857351
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of GSTP1 promotes colorectal cancer cell proliferation, invasion and metastasis by upregulating STAT3.
Wang F; Zhang C; Zhu X; Zhang D; Zhang Z; Ni S; Wang Z; Xu S; Lan X; Ding Y; Liang L
Adv Clin Exp Med; 2022 Feb; 31(2):139-149. PubMed ID: 35195960
[TBL] [Abstract] [Full Text] [Related]
8. [A Case of Isolated Metachronous Splenic Metastasis after Rectal cancer Surgery].
Kuboyama Y; Sumi T; Sahara Y; Fukushima G; Matsumoto M; Matsudo T; Tachibana S; Mimuro H; Ishibashi Y; Katsumata K; Tsuchida A
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1688-1690. PubMed ID: 35046298
[TBL] [Abstract] [Full Text] [Related]
9. [A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal cancer].
Tsujio G; Muguruma K; Eguchi S; Iseki Y; Miki Y; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Nagahara H; Toyokawa T; Tanaka H; Lee S; Yashiro M; Ohira M
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2073-2075. PubMed ID: 35045497
[TBL] [Abstract] [Full Text] [Related]
10. Impact of new cancer therapies on outpatient treatment delivery for colorectal cancer: A population-based study.
Chen L; Speers CH; Cheung WY; Spinelli JJ; Kennecke HF
Int J Health Plann Manage; 2022 Jan; 37(1):258-270. PubMed ID: 34545610
[TBL] [Abstract] [Full Text] [Related]
11. FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer.
Adenis A; Mazard T; Fraisse J; Chalbos P; Pastor B; Evesque L; Ghiringhelli F; Mollevi C; Delaine S; Ychou M
BMC Cancer; 2021 May; 21(1):564. PubMed ID: 34001059
[TBL] [Abstract] [Full Text] [Related]
12. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.
Wang W; Wang H; Xiang L; Ni T; Jin F; Deng J; Zhang Y; Shintaro I; Zhou Y; Liu Y
Oncol Rep; 2020 Jul; 44(1):77-90. PubMed ID: 32627002
[TBL] [Abstract] [Full Text] [Related]
13. Microarray Analysis of Gene Expression Involved in Butyrate-Resistant colorectal Carcinoma HCT116 Cells.
Khonthun C; Saikachain N; Popluechai S; Kespechara K; Hiranyakas A; Srikummool M; Surangkul D
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1739-1746. PubMed ID: 32592372
[TBL] [Abstract] [Full Text] [Related]
14. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract] [Full Text] [Related]
15. SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours.
López-Sánchez LM; Jiménez-Izquierdo R; Peñarando J; Mena R; Guil-Luna S; Toledano M; Conde F; Villar C; Díaz C; Ortea I; De la Haba-Rodríguez JR; Aranda E; Rodríguez-Ariza A
J Cell Mol Med; 2019 Dec; 23(12):8219-8232. PubMed ID: 31560832
[TBL] [Abstract] [Full Text] [Related]
16. Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients.
Kurk SA; Stellato RK; Peeters PHM; Dorresteijn B; Jourdan M; Oskam MJ; Punt CJA; Koopman M; May AM
Am J Clin Nutr; 2019 Dec; 110(6):1395-1403. PubMed ID: 31515555
[TBL] [Abstract] [Full Text] [Related]
17. Effects of Polar Steroids from the Starfish
Malyarenko OS; Malyarenko TV; Kicha AA; Ivanchina NV; Ermakova SP
Molecules; 2019 Aug; 24(17):. PubMed ID: 31470638
[TBL] [Abstract] [Full Text] [Related]
18. [The Significance and Limitations of Curative Resection for Peritoneal Metastases of colorectal cancer].
Yokomizo H; Yoshimatsu K; Yano Y; Okayama S; Sakuma A; Satake M; Yamada Y; Matsumoto A; Usui T; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Kato H; Naritaka Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1446-1448. PubMed ID: 28133018
[TBL] [Abstract] [Full Text] [Related]
19. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract] [Full Text] [Related]
20. Trends in anemia treatment among patients with five non-myeloid malignancies treated with chemotherapy in a large integrated health care delivery system in California, 2000-2013.
Xu L; Xu H; Cannavale K; Sattayapiwat O; Rodriguez R; Page JH; Chao C
Support Care Cancer; 2016 Jul; 24(7):2989-98. PubMed ID: 26872791
[TBL] [Abstract] [Full Text] [Related]
[Next]
